Paul A. Kyrle

17.7k total citations · 4 hit papers
209 papers, 11.8k citations indexed

About

Paul A. Kyrle is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul A. Kyrle has authored 209 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Hematology, 118 papers in Internal Medicine and 85 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul A. Kyrle's work include Venous Thromboembolism Diagnosis and Management (118 papers), Blood Coagulation and Thrombosis Mechanisms (94 papers) and Atrial Fibrillation Management and Outcomes (62 papers). Paul A. Kyrle is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (118 papers), Blood Coagulation and Thrombosis Mechanisms (94 papers) and Atrial Fibrillation Management and Outcomes (62 papers). Paul A. Kyrle collaborates with scholars based in Austria, United States and Germany. Paul A. Kyrle's co-authors include Sabine Eichinger, Klaus Lechner, Ansgar Weltermann, Mirko Hirschl, Thomas Thiele, Theodore E. Warkentin, Andreas Greinacher, Karin Weißer, Ingrid Pabinger and Christine Bialonczyk and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paul A. Kyrle

201 papers receiving 11.4k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

2021 1.4k citations Paul A. Kyrle, Sabine Eichinger et al. profile →
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations Paul A. Kyrle et al. profile →
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

2000 568 citations Paul A. Kyrle, Mirko Hirschl et al. profile →
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

2016 401 citations Suzanne C. Cannegieter, Paul A. Kyrle et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul A. Kyrle Austria	52	6.2k	5.8k	3.9k	2.6k	1.6k	209	11.8k
Ingrid Pabinger Austria	73	10.5k 1.7×	9.3k 1.6×	6.1k 1.5×	2.5k 0.9×	1.4k 0.9×	541	20.3k
John G. Kelton Canada	66	9.2k 1.5×	4.7k 0.8×	2.2k 0.6×	7.6k 2.9×	2.5k 1.6×	236	16.3k
Armando D’Angelo Italy	46	3.0k 0.5×	2.6k 0.5×	2.4k 0.6×	1.9k 0.7×	950 0.6×	192	9.1k
Adam Cuker United States	46	4.2k 0.7×	3.0k 0.5×	2.5k 0.6×	2.4k 0.9×	658 0.4×	224	9.0k
Wendy Lim Canada	41	3.8k 0.6×	4.3k 0.8×	3.5k 0.9×	2.4k 0.9×	508 0.3×	112	10.0k
Paolo Simioni Italy	51	5.3k 0.8×	5.8k 1.0×	3.6k 0.9×	2.2k 0.8×	471 0.3×	415	12.3k
Ian Mackie United Kingdom	52	4.4k 0.7×	1.8k 0.3×	1.8k 0.5×	1.4k 0.5×	1.9k 1.2×	227	9.7k
Cihan Ay Austria	57	3.5k 0.6×	7.6k 1.3×	4.7k 1.2×	2.0k 0.7×	1.1k 0.7×	384	12.8k
Anna Falanga Italy	65	5.1k 0.8×	9.2k 1.6×	5.3k 1.4×	2.3k 0.9×	703 0.5×	299	16.8k
Benjamin Brenner Israel	55	4.6k 0.7×	4.3k 0.7×	4.0k 1.0×	1.6k 0.6×	758 0.5×	329	11.5k

Countries citing papers authored by Paul A. Kyrle

Since Specialization

Citations

This map shows the geographic impact of Paul A. Kyrle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Kyrle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Kyrle more than expected).

Fields of papers citing papers by Paul A. Kyrle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Kyrle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Kyrle. The network helps show where Paul A. Kyrle may publish in the future.

Co-authorship network of co-authors of Paul A. Kyrle

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Kyrle. A scholar is included among the top collaborators of Paul A. Kyrle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Kyrle. Paul A. Kyrle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Traby, Ludwig, Alexandra Kaider, Marietta Kollars, et al.. (2018). Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial. Thrombosis Research. 167. 149–155. 7 indexed citations

Dronkers, C.E.A., Yvonne M. Ende-Verhaar, Paul A. Kyrle, et al.. (2017). Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 15(11). 2270–2273. 17 indexed citations

Dronkers, C.E.A., Tom van der Hulle, Grégoire Le Gal, et al.. (2017). Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 15(5). 1040–1043. 79 indexed citations

Marcucci, Maura, Alfonso Iorio, James D. Douketis, et al.. (2015). Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data. Journal of Thrombosis and Haemostasis. 13(5). 775–781. 43 indexed citations

Roach, R.E.J., Willem M. Lijfering, Robert C. Tait, et al.. (2015). Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts. Journal of Thrombosis and Haemostasis. 13(10). 1815–1822. 21 indexed citations

Eischer, Lisbeth, Sabine Eichinger, & Paul A. Kyrle. (2014). The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study. Journal of Thrombosis and Haemostasis. 12(5). 635–640. 39 indexed citations

Kollars, Marietta, et al.. (2010). Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans. European Journal of Clinical Investigation. 40(6). 477–482. 27 indexed citations

Eichinger, Sabine, et al.. (2010). Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism. Circulation. 121(14). 1630–1636. 360 indexed citations

Eichinger, Sabine, Marietta Kollars, Ludwig Traby, et al.. (2009). Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa. European Journal of Clinical Investigation. 39(8). 707–713. 17 indexed citations

10.

Eischer, Lisbeth, et al.. (2008). 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology. 88(5). 485–490. 36 indexed citations

11.

Mustafa, Stefan, Ansgar Weltermann, Claudia Marsik, et al.. (2008). Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism. Journal of Vascular Surgery. 47(3). 566–570. 35 indexed citations

12.

Alguel, Guelay, Rainer Vormittag, Ralph Simanek, et al.. (2006). Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy. Thrombosis and Haemostasis. 96(9). 285–289. 8 indexed citations

13.

Pabinger, Ingrid, Helga Grafenhofer, Alexandra Kaider, et al.. (2005). Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis. Journal of Thrombosis and Haemostasis. 3(5). 949–954. 155 indexed citations

14.

Weltermann, A., Sabine Eichinger, Christine Bialonczyk, et al.. (2003). The risk of recurrent venous thromboembolism among patients with high factor IX levels. Journal of Thrombosis and Haemostasis. 1(1). 28–32. 70 indexed citations

15.

Quehenberger, Peter, Sylvia Handler, Christine Mannhalter, Paul A. Kyrle, & Wolfgang Speiser. (1999). The Factor V (Leiden) Test. Thrombosis Research. 96(2). 125–133. 18 indexed citations

16.

Füreder, Wolfgang, Paul A. Kyrle, Heinz Gisslinger, & Klaus Lechner. (1998). Low-molecular-weight heparin-induced skin necrosis. Annals of Hematology. 77(3). 127–130. 9 indexed citations

17.

Jaeger, Ulrich, S. Kapiotis, Ingrid Pabinger, et al.. (1993). Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection. Annals of Hematology. 67(2). 95–99. 54 indexed citations

18.

Eichler, H G, et al.. (1992). Absence of interaction between tenoxicam and warfarin. European Journal of Clinical Pharmacology. 42(2). 227–229. 6 indexed citations

19.

Geißler, Klaus, P Kalhs, Paul Knöbl, et al.. (1992). Effect of Interleukin-3 on Responsiveness to Granulocyte-Colony-stimulating Factor in Severe Aplastic Anemia. Annals of Internal Medicine. 117(3). 223–225. 18 indexed citations

20.

Pietschmann, Peter, W. Woloszczuk, Simon Panzer, Paul A. Kyrle, & J. S. Smolen. (1988). Decreased Serum Osteocalcin Levels in Phenprocoumon-Treated Patients. The Journal of Clinical Endocrinology & Metabolism. 66(5). 1071–1074. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact